To validate whether the effects of OCIAD2 knockdown on cellfunctionsare universal in lung cancer cells, the functional assays were conductedin NCI-H322 M cells, which exhibit higher mRNA expression of OCIAD2(Figure S3A). The gene discussed is OCIAD2; the disease is lung carcinoma.